- Home
- MMLP vs ALEC Comparison
MMLP vs ALEC Comparison
Compare MMLP & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMLP
- ALEC
- Stock Information
- Founded
- MMLP 2002
- ALEC 2013
- Country
- MMLP United States
- ALEC United States
- Employees
- MMLP N/A
- ALEC N/A
- Industry
- MMLP Oil Refining/Marketing
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MMLP Energy
- ALEC Health Care
- Exchange
- MMLP Nasdaq
- ALEC Nasdaq
- Market Cap
- MMLP 139.6M
- ALEC 124.0M
- IPO Year
- MMLP 2002
- ALEC 2019
- Fundamental
- Price
- MMLP $3.10
- ALEC $1.47
- Analyst Decision
- MMLP
- ALEC Buy
- Analyst Count
- MMLP 0
- ALEC 7
- Target Price
- MMLP N/A
- ALEC $4.70
- AVG Volume (30 Days)
- MMLP 72.2K
- ALEC 679.0K
- Earning Date
- MMLP 07-16-2025
- ALEC 08-06-2025
- Dividend Yield
- MMLP 0.65%
- ALEC N/A
- EPS Growth
- MMLP N/A
- ALEC N/A
- EPS
- MMLP N/A
- ALEC N/A
- Revenue
- MMLP $719,335,000.00
- ALEC $88,339,000.00
- Revenue This Year
- MMLP $4.19
- ALEC N/A
- Revenue Next Year
- MMLP N/A
- ALEC $319.82
- P/E Ratio
- MMLP N/A
- ALEC N/A
- Revenue Growth
- MMLP N/A
- ALEC N/A
- 52 Week Low
- MMLP $2.56
- ALEC $0.87
- 52 Week High
- MMLP $4.13
- ALEC $6.78
- Technical
- Relative Strength Index (RSI)
- MMLP 50.73
- ALEC 53.71
- Support Level
- MMLP $3.02
- ALEC $1.37
- Resistance Level
- MMLP $3.47
- ALEC $1.62
- Average True Range (ATR)
- MMLP 0.18
- ALEC 0.13
- MACD
- MMLP 0.00
- ALEC -0.01
- Stochastic Oscillator
- MMLP 32.73
- ALEC 46.34
About MMLP Martin Midstream Partners L.P. Limited Partnership
Martin Midstream Partners LP has a diverse set of operations focused in the United States Gulf Coast region. The company's business lines include terminalling, processing, storage, and packaging services for petroleum products and by-products including the refining of naphthenic crude oil; land and marine transportation services for petroleum products and by-products, chemicals, and specialty products; sulfur and sulfur-based products processing, manufacturing, marketing and distribution; and natural gas liquids marketing, distribution and transportation services. Company operates in four segment Terminalling and storage, Transportation, Sulfur service and Specialty products segment. Majority of the revenue derived from Specialty products segment.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.